Why J&J’s CEO Calls AI a Healthcare 'Force Multiplier'
Johnson & Johnson CEO Joaquin Duato explains how the company uses AI to cut drug-development timelines from nearly a decade to a few years, and how the technology is improving surgical outcomes. Photo: Anna Moffat for the WSJ Leadership Institute
2:07
WSJ Leadership Institute Presents: Leaders
The WSJ Leadership Institute Presents: Leaders. A new podcast series bringing you revealing conversations with top executives shaping business today. Hosted by Alan Murray, president of the WSJ Leadership Institute, the series goes beyond headlines to explore how leadership really works in times of upheaval, transformation, and uncertainty. Our first episode was released Monday, Sept. 22, at 5:00 a.m. ET, with new episodes every other Monday.